Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
supplied in 0.1 M Tris buffer with 0.002 % Kathon CG
Lagerung
4 °C
Haltbarkeit
18 months
Kim, Liebowitz, Lin, Kasparek, Pasetti, Garg, Gottlieb, Trager, Tucker: "Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial." in: JCI insight, Vol. 3, Issue 13, (2019) (PubMed).
Sánchez Ramírez, Morera Díaz, Bequet-Romero, Hernández-Bernal, Selman-Housein Bernal, de la Torre Santos, Santiesteban Álvarez, Martín Bauta, Bermúdez Badell, de la Torre Pupo, Gavilondo, Ayala Avila: "Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants." in: BMC immunology, Vol. 18, Issue 1, pp. 39, (2018) (PubMed).
Gao, Lin, Yu: "Ex Vivo Culture Assay to Measure Human Follicular Helper T (Tfh) Cell-Mediated Human B Cell Proliferation and Differentiation." in: Methods in molecular biology (Clifton, N.J.), Vol. 1707, pp. 111-119, (2018) (PubMed).
Colombo, Pereira, da Silva, Ribas, Parisotto, Mattos-Graner, Smith, Duque: "Relationship between the IgA antibody response against Streptococcus mutans GbpB and severity of dental caries in childhood." in: Archives of oral biology, Vol. 67, pp. 22-7, (2017) (PubMed).
De Bruyne, Bogaert, De Ruyck, Lambrecht, Van Winckel, Gevaert, Dullaers: "Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells." in: Clinical and experimental immunology, Vol. 180, Issue 3, pp. 542-50, (2015) (PubMed).